• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

切除的胰腺癌患者原发肿瘤和转移淋巴结中SPARC表达与患者生存之间的关系。

The relationship between SPARC expression in primary tumor and metastatic lymph node of resected pancreatic cancer patients and patients' survival.

作者信息

Yu Xin-Zhe, Guo Zhong-Yi, Di Yang, Yang Feng, Ouyang Qi, Fu De-Liang, Jin Chen

机构信息

Department of Pancreatic Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China.

出版信息

Hepatobiliary Pancreat Dis Int. 2017 Feb;16(1):104-109. doi: 10.1016/s1499-3872(16)60168-6.

DOI:10.1016/s1499-3872(16)60168-6
PMID:28119265
Abstract

BACKGROUND

Previous researches in pancreatic cancer demonstrated a negative correlation between secreted protein acidic and rich in cysteine (SPARC) expression in primary tumor and survival, but not for SPARC expression in lymph node. In the present study, we aimed to evaluate the SPARC expression in various types of tissues and its impact on patients' prognosis.

METHODS

The expression of SPARC was examined by immunohistochemistry in resected pancreatic cancer specimens. Kaplan-Meier analyses and Cox proportional hazards regression were applied to assess the mortality risk.

RESULTS

A total of 222 tissue samples from 73 patients were collected to evaluate the SPARC expression, which included 73 paired primary tumor and adjacent normal tissues, 38 paired metastatic and normal lymph nodes. The proportion of positive SPARC expression in metastatic lymph node was high (32/38), whereas in normal lymph node it was negative (0/38). Positive SPARC expression in primary tumor cells was associated with a significantly decreased overall survival (P=0.007) and disease-free survival (P=0.003), whereas in other types of tissues it did not show a predictive role for prognosis. Univariate and multivariate analyses both confirmed this significance.

CONCLUSION

SPARC can serve a dual function role as both predictor for prognosis and potentially biomarker for lymph node metastasis in resected pancreatic cancer patients.

摘要

背景

先前关于胰腺癌的研究表明,原发性肿瘤中富含半胱氨酸的酸性分泌蛋白(SPARC)的表达与生存率呈负相关,但在淋巴结中SPARC的表达与生存率无关。在本研究中,我们旨在评估SPARC在各种组织类型中的表达及其对患者预后的影响。

方法

通过免疫组织化学检测切除的胰腺癌标本中SPARC的表达。应用Kaplan-Meier分析和Cox比例风险回归评估死亡风险。

结果

共收集了73例患者的222个组织样本以评估SPARC的表达,其中包括73对原发性肿瘤和癌旁正常组织、38对转移淋巴结和正常淋巴结。转移淋巴结中SPARC阳性表达的比例较高(32/38),而正常淋巴结中均为阴性(0/38)。原发性肿瘤细胞中SPARC阳性表达与总生存期(P=0.007)和无病生存期(P=0.003)显著降低相关,而在其他组织类型中,其对预后未显示出预测作用。单因素和多因素分析均证实了这一显著性。

结论

SPARC在接受手术切除的胰腺癌患者中可作为预后预测指标和潜在的淋巴结转移生物标志物,具有双重作用。

相似文献

1
The relationship between SPARC expression in primary tumor and metastatic lymph node of resected pancreatic cancer patients and patients' survival.切除的胰腺癌患者原发肿瘤和转移淋巴结中SPARC表达与患者生存之间的关系。
Hepatobiliary Pancreat Dis Int. 2017 Feb;16(1):104-109. doi: 10.1016/s1499-3872(16)60168-6.
2
Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.胰腺腺癌的淋巴结转移模式和预后:直接淋巴结侵犯的生存情况与淋巴结阴性疾病相似。
Am J Surg Pathol. 2011 Feb;35(2):228-34. doi: 10.1097/PAS.0b013e318206c37a.
3
The role of SPARC expression in pancreatic cancer progression and patient survival.SPARC表达在胰腺癌进展及患者生存中的作用。
Scand J Gastroenterol. 2015;50(9):1170-4. doi: 10.3109/00365521.2015.1024281. Epub 2015 Mar 12.
4
Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome.远端胆管癌进展过程中肿瘤周围组织中 SPARC 的表达及其与预后的关系。
Scand J Gastroenterol. 2020 Jun;55(6):725-731. doi: 10.1080/00365521.2020.1774923. Epub 2020 Jun 16.
5
Mortalin expression in pancreatic cancer and its clinical and prognostic significance.Mortalin在胰腺癌中的表达及其临床和预后意义。
Hum Pathol. 2017 Jun;64:171-178. doi: 10.1016/j.humpath.2017.03.015. Epub 2017 Apr 12.
6
Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma.淋巴结转移数目而非淋巴结比率是胰腺癌切除术后的独立预后因素。
J Am Coll Surg. 2010 Aug;211(2):196-204. doi: 10.1016/j.jamcollsurg.2010.03.037. Epub 2010 Jun 8.
7
CA19-9 level determines therapeutic modality in pancreatic cancer patients with para-aortic lymph node metastasis.CA19-9 水平决定了伴有腹主动脉旁淋巴结转移的胰腺癌患者的治疗方式。
Hepatobiliary Pancreat Dis Int. 2018 Feb;17(1):75-80. doi: 10.1016/j.hbpd.2018.01.004.
8
Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.胰腺导管腺癌的全胰切除术:美国国立癌症数据库综述
HPB (Oxford). 2016 Jan;18(1):21-8. doi: 10.1016/j.hpb.2015.07.009. Epub 2015 Dec 21.
9
Pancreatic cancer metastatic to a limited number of lymph nodes has no impact on outcome.胰腺癌转移至少数淋巴结对预后无影响。
HPB (Oxford). 2016 Jun;18(6):523-8. doi: 10.1016/j.hpb.2016.02.004.
10
Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival.重新定义胰腺导管腺癌的 R1 切除术:肿瘤淋巴结负担和淋巴结比率是与生存相关的唯一预后因素。
HPB (Oxford). 2013 Sep;15(9):674-80. doi: 10.1111/hpb.12019. Epub 2013 Jan 14.

引用本文的文献

1
Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy.肿瘤免疫调节中的细胞外基质动态变化:从肿瘤微环境到免疫治疗
J Hematol Oncol. 2025 Jun 19;18(1):65. doi: 10.1186/s13045-025-01717-y.
2
hENT1's role in adjuvant intra-arterial gemcitabine-based chemotherapy for resectable pancreatic cancer patients.hENT1 在可切除胰腺癌患者辅助动脉内吉西他滨化疗中的作用。
BMC Gastroenterol. 2023 Feb 8;23(1):35. doi: 10.1186/s12876-023-02666-x.
3
Prognostic significance of SPARC expression in non-small cell lung cancer: A meta-analysis and bioinformatics analysis.
SPARC表达在非小细胞肺癌中的预后意义:一项荟萃分析和生物信息学分析
Oncol Lett. 2022 Sep 27;24(5):412. doi: 10.3892/ol.2022.13532. eCollection 2022 Nov.
4
The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma.胰腺导管腺癌中肝转移和预后相关基因的鉴定。
BMC Cancer. 2022 Apr 27;22(1):463. doi: 10.1186/s12885-022-09577-2.
5
SPARC promotes pancreatic cancer cell proliferation and migration through autocrine secretion into the extracellular milieu.SPARC通过自分泌进入细胞外环境促进胰腺癌细胞的增殖和迁移。
Oncol Lett. 2021 Jun;21(6):485. doi: 10.3892/ol.2021.12746. Epub 2021 Apr 21.
6
Identification of key genes involved in the development and progression of early-onset colorectal cancer by co-expression network analysis.通过共表达网络分析鉴定早发性结直肠癌发生发展过程中的关键基因
Oncol Lett. 2020 Jan;19(1):177-186. doi: 10.3892/ol.2019.11073. Epub 2019 Nov 8.
7
Prognostic role of secreted protein acidic and rich in cysteine in patients with solid tumors.富含半胱氨酸的酸性分泌蛋白在实体瘤患者中的预后作用。
Saudi Med J. 2019 Aug;40(8):755-765. doi: 10.15537/smj.2019.8.24379.
8
Low expression of SPARC in gastric cancer-associated fibroblasts leads to stemness transformation and 5-fluorouracil resistance in gastric cancer.胃癌相关成纤维细胞中SPARC的低表达导致胃癌的干性转化和5-氟尿嘧啶耐药。
Cancer Cell Int. 2019 May 21;19:137. doi: 10.1186/s12935-019-0844-8. eCollection 2019.
9
The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection.SPARC表达对胰腺导管腺癌患者根治性切除术后生存的影响。
J Cancer. 2019 Jan 1;10(3):627-633. doi: 10.7150/jca.28660. eCollection 2019.
10
Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods.通过综合生物信息学方法鉴定胰腺导管腺癌中的枢纽基因并分析其预后价值
Mol Biol Rep. 2018 Dec;45(6):1799-1807. doi: 10.1007/s11033-018-4325-2. Epub 2018 Sep 1.